Both in Pharmaceuticals
ALX Oncology Holdings vs Oramed Pharmaceuticals
Over the past year ALXO returned −20.8% and ORMP returned +72.0%; their daily moves had a correlation of 0.05.
ALXO −20.8% ORMP +72.0%Growth of $1, one year, split-adjusted
| Metric | ALXO | ORMP |
|---|---|---|
| Price | $1.22 | $4.11 |
| Market cap | $168.7M | $171.0M |
| Today | 0.00% | −2.84% |
| 1 month | −6.2% | −8.3% |
| 6 months | −27.8% | +3.3% |
| Year to date | +8.0% | +44.2% |
| 1 year | −23.3% | +73.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.0× |
| Price / sales | — | — |
| Net cash | $128.5M | $50.6M |
| Dividend yield | — | 6.08% |
| Volatility (60d) | 88.9% | 35.8% |
| Short % of float | 6.5% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).